Summary
Tiziana Life Sciences Plc (Tiziana) formerly Alexander David Investments is a clinical stage biotechnology company that discovers and develops innovative drugs for the treatment of various types of cancer with particular focus on late stage metastases. Tiziana’ discovery of the Bcl-3 gene playing a prominent role in halting cancer metastasis forms the core of its R&D efforts. Its R&D pipeline includes clinical stage candidates, Milciclib, a CDK inhibitor in Phase II clinical trials for the treatment of thymoma and in Phase I for liver cancer; and foralumab, CD3 antibody in Phase I for the treatment of inflammatory bowel disease. Its preclinical stage candidates include TZLS-101, Bcl-3 targeting breast cancer and TZLS-214, a c-FLIP inhibitor targeting cancer. The company has agreements with the University of Cardiff; TTFactor S.r.l; Novimmune SA; and Neriviano Medical Sciences. Tiziana is headquartered in London, the UK.
Tiziana Life Sciences Plc (TILS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Tiziana Life Sciences Plc, Medical Devices Deals, 2011 to YTD 2017 9
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Tiziana Life Sciences Acquires Bio-Repository from Shardna for USD0.3 Million 11
Licensing Agreements 12
Tiziana Life Sciences Enters into Licensing Agreement with Novimmune 12
Tiziana Life Sciences Enters into Licensing Agreement with Novimmune for Foralumab 13
Tiziana Life Sciences Enters into Licensing Agreement with Cardiff University 14
Tiziana Life Sciences Enters into Licensing Agreement with Nerviano Medical Sciences for Milciclib 15
Equity Offering 16
Tiziana Life Sciences Raises USD0.7 Million in Private Placement of Shares upon Exercise of Warrants 16
Tiziana Life Sciences to Raise USD0.1 Million in Private Placement of Shares upon Exercise of Warrants 17
Tiziana Life Sciences to Raise USD0.3 Million in Private Placement of Shares upon Exercise of Warrants 18
Tiziana Life Sciences to Raise USD0.1 Million in Private Placement of Shares upon Exercise of Warrants 19
Tiziana Life Sciences Raises USD3.8 Million in Private Placement of Shares 20
Tiziana Life Sciences Completes Placement for USD3.3 Million 21
ReGen Therapeutics Completes Private Placement Of US$2.4 Million 22
Acquisition 23
Alexander David Investments Completes Acquisition of Tiziana Pharma in Reverse Takeover Transaction 23
Tiziana Life Sciences Plc - Key Competitors 24
Tiziana Life Sciences Plc - Key Employees 25
Tiziana Life Sciences Plc - Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 27
Financial Announcements 27
May 23, 2017: Tiziana Life Sciences: Financial Results for the Year Ended 31 December 2016 27
Sep 29, 2016: Tiziana Life Sciences: Interim Results for the Six Months Ended 30 June 2016 29
Jun 07, 2016: Tiziana Life Sciences: Final Results for the year ended 31 December 2015 30
Corporate Communications 31
Jun 12, 2017: Tiziana Life Sciences Strengthens Unique Research Focus by Appointing Dr Kunwar Shailubhai as Chief Executive Officer 31
Mar 14, 2017: Tiziana Life Sciences Appoints Dr. Arun Sanyal to its Scientific Advisory Board 33
Apr 04, 2016: Tiziana Life Sciences Tiziano Lazzaretti Appointed as Chief Financial Officer 34
Product News 35
01/11/2016: Tiziana announces plans for clinical development of foralumab, the company fully human CD3 antibody 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36
List of Tables
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Tiziana Life Sciences Plc, Deals By Therapy Area, 2011 to YTD 2017 8
Tiziana Life Sciences Plc, Medical Devices Deals, 2011 to YTD 2017 9
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Tiziana Life Sciences Acquires Bio-Repository from Shardna for USD0.3 Million 11
Tiziana Life Sciences Enters into Licensing Agreement with Novimmune 12
Tiziana Life Sciences Enters into Licensing Agreement with Novimmune for Foralumab 13
Tiziana Life Sciences Enters into Licensing Agreement with Cardiff University 14
Tiziana Life Sciences Enters into Licensing Agreement with Nerviano Medical Sciences for Milciclib 15
Tiziana Life Sciences Raises USD0.7 Million in Private Placement of Shares upon Exercise of Warrants 16
Tiziana Life Sciences to Raise USD0.1 Million in Private Placement of Shares upon Exercise of Warrants 17
Tiziana Life Sciences to Raise USD0.3 Million in Private Placement of Shares upon Exercise of Warrants 18
Tiziana Life Sciences to Raise USD0.1 Million in Private Placement of Shares upon Exercise of Warrants 19
Tiziana Life Sciences Raises USD3.8 Million in Private Placement of Shares 20
Tiziana Life Sciences Completes Placement for USD3.3 Million 21
ReGen Therapeutics Completes Private Placement Of US$2.4 Million 22
Alexander David Investments Completes Acquisition of Tiziana Pharma in Reverse Takeover Transaction 23
Tiziana Life Sciences Plc, Key Competitors 24
Tiziana Life Sciences Plc, Key Employees 25
Tiziana Life Sciences Plc, Subsidiaries 26
List of Figures
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Tiziana Life Sciences Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Tiziana Life Sciences Plc, Medical Devices Deals, 2011 to YTD 2017 9
